Salinomycin-Loaded Gold Nanoparticles for Treating Cancer Stem Cells by Ferroptosis-Induced Cell Death
- 22 April 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 16 (6) , 2532-2539
Abstract
Cancer Stem Cells (CSCs) are a subpopulation of tumor cells which exhibits self-renewal, differentiation and tumorigenicity. CSCs are highly resistant to conventional cancer treatment and have been associated with metastasis. Several studies have been shown that salinomycin (Sal) has the potential to target cancer stem cells and evidenced by in vitro and in vivo tumor models. Here, salinomycin was conjugated with biocompatible gold nanoparticles (AuNPs) coated with poly(ethylene glycol) (PEG) to improve its specificity in targeting breast cancer stem cells (BCSC). BCSC derived from CD24low/CD44high subpopulation showed high sensitivity to Sal-AuNPs treatment. In-depth analysis on the mechanism of action of Sal-AuNPs indicated ferroptosis, an iron-dependent cell death was achieved as a result of iron accumulation and inhibition of antioxidant properties. This also led to the induction of oxidative stress, mitochondrial dysfunction, and lipid oxidation. Our findings suggest Sal-AuNPs is an efficient therapeutic avenue in eliminating cancer stem cells.Keywords
Funding Information
- National Health and Medical Research Council (1112258)
This publication has 51 references indexed in Scilit:
- Salinomycin as a Drug for Targeting Human Cancer Stem CellsJournal of Biomedicine and Biotechnology, 2012
- Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stressBritish Journal of Cancer, 2012
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cellsProceedings of the National Academy of Sciences, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput ScreeningCell, 2009
- Association of reactive oxygen species levels and radioresistance in cancer stem cellsNature, 2009
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and AngiogenesisJournal of Clinical Oncology, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002